Lombard Medical Technologies PLC

LSE:LMT (UK)  
£ 1.89 (0%) Dec 31
At Loss
P/B:
0.53
Market Cap:
£ 84.34M ($ 107.71M)
Enterprise V:
£ 84.34M ($ 107.71M)
Volume:
-
Avg Vol (2M):
-
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Lombard Medical Technologies PLC ( LSE:LMT ) from 1990 to Jun 06 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Lombard Medical Technologies PLC stock (LSE:LMT) PE ratio as of Jun 06 2024 is 0. More Details

Lombard Medical Technologies PLC (LSE:LMT) PE Ratio (TTM) Chart

To

Lombard Medical Technologies PLC (LSE:LMT) PE Ratio (TTM) Historical Data

Total 0
  • 1
Lombard Medical Technologies PLC PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data

Lombard Medical Technologies PLC (LSE:LMT) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Lombard Medical Technologies PLC is engaged in the design and development of endovascular stent grafts, their manufacture, and commercialization either directly through the group's own sales force or through a network of local distributors supported by clinical specialists from Lombard Medical. The principal product, the AorfixT AAA stent graft has European CE mark approval for use in patients with high-angle-neck aneurysms of up to 90 degrees. The group has operations in United Kingdom and United States of America.